| SNPS Stock | | | USD 547.74 6.21 1.12% |
EVP
Mr. Joseph W. Logan is Sales and Corporationrationrate Marketing Officer of Synopsys Inc. He became Senior Vice President of Worldwide Sales in September 2006, and assumed responsibility for our Corporationrationrate Marketing organization in August 2013. Previously, Mr. Logan was head of sales for Synopsys North America East region from September 2001 to September 2006. Prior to Synopsys, Mr. Logan was head of North American Sales and Support at Avant Corporation since 2017.
| Age | 64 |
| Tenure | 7 years |
| Address | 675 Almanor Avenue, Sunnyvale, CA, United States, 94085 |
| Phone | 650-584-5000 |
| Web | https://www.synopsys.com |
Logan holds a B.S.E.E. from the University of Massachusetts, Amherst.
Synopsys Management Efficiency
The company has return on total asset
(ROA) of
0.0862 % which means that it generated a profit of $0.0862 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
0.2182 %, meaning that it created $0.2182 on every $100 dollars invested by stockholders. Synopsys' management efficiency ratios could be used to measure how well Synopsys manages its routine affairs as well as how well it operates its assets and liabilities.
Return On Tangible Assets is likely to gain to 0.20 in 2024, whereas
Return On Capital Employed is likely to drop 0.15 in 2024. At this time, Synopsys'
Fixed Asset Turnover is comparatively stable compared to the past year.
Asset Turnover is likely to gain to 0.67 in 2024, whereas
Deferred Long Term Asset Charges is likely to drop slightly above 313
M in 2024.
Synopsys currently holds 687.8
M in liabilities with Debt to Equity
(D/E) ratio of 0.12, which may suggest the company is not taking enough advantage from borrowing. Synopsys has a current ratio of 1.12, suggesting that it
may have difficulties to pay its financial obligations when due. Note, when we think about Synopsys' use of debt, we should always consider it together with its cash and equity.
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company was incorporated in 1986 and is headquartered in Mountain View, California. Synopsys operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 16361 people. Synopsys (SNPS) is traded on NASDAQ Exchange in USA. It is located in 675 Almanor Avenue, Sunnyvale, CA, United States, 94085 and employs 20,300 people. Synopsys is listed under Application Software category by Fama And French industry classification.
Management Performance
Synopsys Leadership Team
Elected by the shareholders, the Synopsys' board of directors comprises two types of representatives: Synopsys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Synopsys. The board's role is to monitor Synopsys' management team and ensure that shareholders' interests are well served. Synopsys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Synopsys' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sassine Ghazi, President CEO | |
| Shankar Krishnamoorthy, Head Development | |
| Paul Stravers, Principal Engineer | |
| Shelagh Glaser, Chief Officer | |
| Charlie Matar, Senior Group | |
| John Koeter, Senior Strategy | |
| John Runkel, General Counsel and Corporate Secretary | |
| Joseph Logan, Executive VP of Sales and Corporate Marketing | |
| Sudhindra Kankanwadi, Principal Accounting Officer, Vice President Corporate Controller | |
| Trac Pham, Chief Officer | |
| Deirdre Hanford, Chief Officer | |
| Antonio Varas, Chief Officer | |
| Michael Sanie, VP Communication | |
| Erika McEnroe, Senior Counsel | |
| Aart Geus, Co-Founder, Chairman and Co-CEO | |
| Ann Minooka, Chief Officer | |
| Lisa Ewbank, Vice President - Investor Relations | |
| Alessandra Costa, Senior Group | |
| Richard Mahoney, Chief Officer | |
| Sriram Sitaraman, Senior Officer | |
| Janet Collinson, HR Officer | |
| Jill Larsen, Chief Officer | |
| Jason Schmitt, General Group | |
| Raja Tabet, Senior Group | |
Synopsys Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Synopsys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Synopsys Stock Analysis
When running Synopsys' price analysis, check to
measure Synopsys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopsys is operating at the current time. Most of Synopsys' value examination focuses on studying past and present price action to
predict the probability of Synopsys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synopsys' price. Additionally, you may evaluate how the addition of Synopsys to your portfolios can decrease your overall portfolio volatility.